Product Overview
Generic name: Yimaikang Dispersible Tablets
Chinese Pinyin: Yimaikang Fensan Pian
Product name: Merri
Ingredients: breviscapine extract
Properties: This product is light gray-yellow tablets; the taste is slightly bitter.
Functions and indications: Activating blood circulation to remove blood stasis, used for ischemic cerebrovascular disease and paralysis after cerebral hemorrhage, fundus retinal occlusion, coronary heart disease, vasculitis skin disease, rheumatism; late stage after trabeculectomy with controlled intraocular pressure Glaucoma narrowing of the visual field.
Specifications: Each tablet weighs 0.4g (containing 40mg of total flavonoids)
Usage and dosage: Swallow, or take orally after dispersing with water. 2 tablets at a time, 3 times a day.
Adverse reactions: Unclear.
Taboo: Not clear yet.
Note: Not clear yet.
Drug interactions: Animal test results show that this product can reduce the content of malondialdehyde (MDA) in rabbits with chronic ocular hypertension, increase the activity of superoxide dismutase (SOD); reduce the permeability of retinal blood vessels; The gray scale and density of active ganglion cells in the retina caused by acute ocular hypertension in rats.
Storage: Sealed, kept in a cool and dry place (not exceeding 20℃).
Packaging: PVC rigid film, aluminum-plastic blister packaging. 12 pieces/board×3 boards/box.
Validity period: 18 months.
Executive standard: Standard YBZ01632008 of the State Food and Drug Administration
Approval number: National Medicine Standard Z20080073
Company Name: Hunan Xiangya Pharmaceutical Co., Ltd.
Company Address: Tongzipo, Yuelu District, Changsha City, Hunan Province
